Recruiting NCT06607549
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
Central Nervous System Lymphoma
Hematology
3,640 trials in this section
Recruiting NCT05820841
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma
Large B-cell Lymphoma · Diffuse Large B Cell Lymphoma
Not yet recruiting NCT07672769
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
Higher Risk Myelodysplastic Syndromes
Recruiting NCT06802315
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Acute Myeloid Leukemia, Relapsed, Adult · Acute Myeloid Leukemia Refractory · Chronic Myeloid Leukemia - Accelerated Phase
Recruiting NCT07444632
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Lymphoid · Hodgkin Lymphoma
Recruiting NCT05776212
Quantitative-imaging in Cardiac Transthyretin Amyloidosis
ATTR-CM
Recruiting NCT04515810
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Locally Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Recurrent Hematologic Malignancy
Recruiting NCT06189391
A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Recruiting NCT05489549
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Amyloidosis, Hereditary · Amyloidosis Cardiac · Amyloidosis, Familial
Recruiting NCT07671378
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
CLL (Chronic Lymphocytic Leukemia)
Recruiting NCT07559799
A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)
Multiple Myeloma
Not yet recruiting NCT07671287
GMMG-HD11/DSMM XXI/64007957MMY3010
Multiple Myeloma
Recruiting NCT07140016
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer (NSCLC) · Anaplastic Lymphoma Kinase (ALK) Positive
Recruiting NCT06107738
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Multiple Myeloma
Recruiting NCT07670949
Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies
Hematological Malignancies B
Recruiting NCT05738005
Dietary Reporting In The Amyloidoses
Amyloidosis
Not yet recruiting NCT07649681
Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
Multiple Myeloma (MM) · GI Cancer · Taste Disorder
Recruiting NCT06492707
DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial
Acute Myeloid Leukemia · Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia
Recruiting NCT06420167
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
Renal AL Amyloidosis
Recruiting NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
B-cell Non-Hodgkin Lymphoma · Follicular Lymphoma (FL) · Large B-Cell Lymphoma (LBCL)
Recruiting NCT06447376
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Non-Hodgkin Lymphoma · Cytokine Release Syndrome
Recruiting NCT05749276
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
Recruiting NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Acute Leukemia · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia
Recruiting NCT04869683
Biocollection in MyeloDysplastic Syndrome (P-MDS)
Myelodysplastic Syndromes · Myelodysplastic Anemia · Myelodysplastic Syndrome With Isolated Del(5Q)
Not yet recruiting NCT07669194
Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting NCT05558319
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Newly Diagnosed Multiple Myeloma
Recruiting NCT04094311
Study of Out of Specification for Tisagenlecleucel
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma
Recruiting NCT06785415
Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
Recurrent Multiple Myeloma
Recruiting NCT04664179
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
EBV-Related Hodgkin Lymphoma · EBV-Related Lymphoproliferative Disorder · EBV Related Non-Hodgkin's Lymphoma
Recruiting NCT06544785
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Recruiting NCT04068597
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Haematological Malignancy · Acute Myeloid Leukemia · Non Hodgkin Lymphoma
Recruiting NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Lymphoma · Non-Hodgkin Lymphoma · Hodgkin Lymphoma
Not yet recruiting NCT07637526
Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma
Relapse Multiple Myeloma
Not yet recruiting NCT07614360
Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT03516617
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Recruiting NCT06285890
Phase I Study of HC-7366 for Acute Myeloid Leukemia
Acute Myeloid Leukemia
Recruiting NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma (FL)
Recruiting NCT06466395
A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
Refractory Acute Leukemia · Relapsed Acute Leukemia · Undifferentiated Leukemia
Recruiting NCT07300735
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Hematologic Malignancy · Neutropenia · Bone Pain
Recruiting NCT06399640
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Relapsed Myelodysplastic Syndrome · Refractory Myelodysplastic Syndrome · Acute Myeloid Leukemia
Not yet recruiting NCT07249476
Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
Leukaemia (Acute Myeloid) · Leukaemia (Acute Lymphoblastic) · Myelodysplastic Syndrome
Not yet recruiting NCT07664839
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
Acute Myeloid Leukemia · NPM1 Mutation · IDH1 Mutation
Recruiting NCT07468136
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Anaplastic Oligodendroglioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4
Recruiting NCT03829540
CD4CAR for CD4+ Leukemia and Lymphoma
T-cell Lymphoma · T-cell Leukemia
Recruiting NCT05262673
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
B-Cell Acute Lymphoblastic Leukemia
Not yet recruiting NCT07572929
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
Myeloid Disorders · Myelodysplastic Syndromes · Myeloproliferative Neoplasm
Enrolling by invitation NCT07299123
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
Severe Aplastic Anemia (SAA) · Severe Aplastic Anemia, Refractory · Severe Aplastic Anemia
Recruiting NCT06648889
Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
T-ALL
Recruiting NCT05401097
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Acute Myeloid Leukemia
Recruiting NCT05850234
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Relapsed/Refractory Multiple Myeloma
Recruiting NCT06435910
Engineered Dendritic Cell Vaccines for Multiple Myeloma
Multiple Myeloma or Plasmacytoma
Recruiting NCT07663253
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
Multiple Myeloma
Recruiting NCT04510636
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Classical Hodgkin Lymphoma · Relapsed Cancer · Refractory Cancer
Recruiting NCT07662369
CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation
Hematologic Malignancy · Haplo-identical HCT
Not yet recruiting NCT07662928
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
Adult Burkitt Lymphoma
Not yet recruiting NCT07283640
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
Blinatumomab · Revumenib · Lymphoblastic Leukemia
Recruiting NCT05995028
Universal 4SCAR7U Targeting CD7-positive Malignancies
T-cell Acute Lymphoblastic Leukemia · T-cell Acute Lymphoblastic Lymphoma · Acute Myeloid Leukemia
Not yet recruiting NCT07247097
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
Multiple Myeloma · Newly Diagnosed Multiple Myeloma · Transplant Ineligible
Recruiting NCT06551584
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Acute Myeloid Leukemia · Acute Lymphoid Leukemia · Mixed Phenotype Acute Leukemia
Recruiting NCT05277753
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
T-Cell Acute Lymphoblastic Leukemia
Not yet recruiting NCT07147751
Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)
Recruiting NCT05700149
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma
Not yet recruiting NCT07485569
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
Thyroid Cancer Stage IV · Anaplastic Thyroid Cancer · Differentiated Thyroid Cancer
Recruiting NCT03128034
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia
Recruiting NCT05756777
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML)
Recruiting NCT06090539
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Relapsed/Refractory Non-Hodgkin Lymphoma
Not yet recruiting NCT07563010
Menin-Inhibitor Targeted Maintenance in AML
Relapsed Adult AML · Stem Cell Transplant Complications · Acute Myeloid Leukemia
Recruiting NCT07205666
The Eplontersen Pregnancy and Lactation Outcomes Study
Transthyretin Amyloidosis
Recruiting NCT02134574
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Hematologic Malignancy
Recruiting NCT07080970
Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
Acute Myeloid Leukemia · NPM1 Mutation
Recruiting NCT06224855
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Advanced Solid Tumors · Hematological Malignancies
Recruiting NCT07356154
A Study of Revumenib and Mezigdomide in People With Leukemia
Leukemia · Acute Leukemia · Relapse Leukemia
Recruiting NCT04581512
Study to Evaluate the Safety and Tolerability of EP0042
Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndromes
Recruiting NCT07661095
A Study of CRD3874-SI in People With Leukemia
Acute Myeloid Leukemia · AML · Refractory Acute Myeloid Leukemia
Recruiting NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Relapsed/Refractory Systemic Light Chain Amyloidosis
Not yet recruiting NCT07652476
Neurocognitive Assessment in Long-Term Survivors of Lymphoma
Classic Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL) · Primary Mediastinal B Cell Lymphoma
Recruiting NCT06977711
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
Diffuse Large B-cell Lymphoma
Not yet recruiting NCT07658352
A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
B-Cell Non-Hodgkin Lymphoma
Not yet recruiting NCT07376330
Molecular and Cellular Characterization of MALT Lymphoma
MALT Lymphoma
Not yet recruiting NCT07660939
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
Plasma Cell Disorders · Multiple Myeloma (MM)
Not yet recruiting NCT07658924
Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma · Mycosis Fungoides (MF)
Recruiting NCT01624805
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Aplastic Anemia · de Novo Myelodysplastic Syndrome · Myelodysplastic Syndrome
Recruiting NCT06898905
Hyperfractionated Dual Equivalent Fractionated Radiation Therapy
Diffuse Large B-Cell Lymphoma
Recruiting NCT07319897
68Ga-BCMA PET/CT in Multiple Myeloma
Multiple Myeloma · Multiple Myeloma and Malignant Plasma Cell Neoplasms · Multiple Myeloma and Plasma Cell Neoplasm
Not yet recruiting NCT07592481
Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors
Chronic Lymphocytic Leukemia (CLL) · Follicular Lymphoma ( FL) · Waldenstrom Macroglobulinaemia
Recruiting NCT05549661
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Recurrent Chronic Myelomonocytic Leukemia · Refractory Chronic Myelomonocytic Leukemia · Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified
Recruiting NCT07154264
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recruiting NCT03670966
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia in Remission
Recruiting NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Acute Myeloid Leukemia · Leukemia
Recruiting NCT06971848
Evaluation of Skin Tests in Biotherapy Allergies
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck · Melanoma Neoplasms · Small Cell Bronchial Carcinomas
Recruiting NCT07507318
Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission
Diffuse Large B-Cell Lymphoma
Recruiting NCT07215585
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Large B-cell Lymphoma
Recruiting NCT04566328
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma · RISS Stage I Plasma Cell Myeloma · RISS Stage II Plasma Cell Myeloma
Recruiting NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
IDH1 Mutation · Acute Myeloid Leukemia (AML) · Hematopoietic Stem Cell Transplant (HSCT)
Recruiting NCT07502768
Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma
Extranodal NK/T-cell Lymphoma · NK/T-cell Lymphoma · Relapsed or Refractory NK/T-Cell Lymphoma
Recruiting NCT06002828
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Hodgkin Lymphoma · Non-Hodgkin Lymphoma
Not yet recruiting NCT07607925
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
Lymphoma, Non-Hodgkin
Not yet recruiting NCT07657572
A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.
PTCL · T Cell Lymphoma
Recruiting NCT03937635
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Recruiting NCT07065344
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
Hematology · Diffused Large B Cell Lymphoma